Literature DB >> 3661619

5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.

B Patel1, R A Kloner, J Ensley, M Al-Sarraf, J Kish, J Wynne.   

Abstract

Seven patients developed clinical features simulating myocardial ischemia less than 72 hours after 12 of 13 separate intravenous 5-fluorouracil administrations; 9 episodes were associated with chest pain, 3 with hypotension, 3 with ventricular tachycardia and 1 with cardiogenic shock. Left ventricular dysfunction was demonstrated by echocardiography in 5 separate episodes, 2 with interval improvement upon repeat echocardiograms. Pretreatment with nitrates and/or calcium channel blockers failed to prevent recurrence of cardiotoxicity during 5 of 6 repeat 5-fluorouracil administrations. Therapy with 5-fluorouracil is associated with cardiotoxicity simulating myocardial ischemia with left ventricular dysfunction. Pretreatment with coronary vasodilators may not prevent this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661619     DOI: 10.1097/00000441-198710000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  23 in total

Review 1.  Ischemic Heart Disease: Special Considerations in Cardio-Oncology.

Authors:  Dana Elena Giza; Fernando Boccalandro; Juan Lopez-Mattei; Gloria Iliescu; Kaveh Karimzad; Peter Kim; Cezar Iliescu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

2.  Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.

Authors:  Paurush Ambesh; Kaveh Zivari; Chukwudi Obiagwu; Vijay Shetty; Stephan Kamholz; Gerald Hollander; Jacob Shani
Journal:  Br J Clin Pharmacol       Date:  2018-02-09       Impact factor: 4.335

3.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 4.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 5.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 6.  Cardiotoxicity of cancer chemotherapy: implications for children.

Authors:  Valeriano C Simbre; Sarah A Duffy; Gul H Dadlani; Tracie L Miller; Steven E Lipshultz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

7.  Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy.

Authors:  Christopher James Little; Bao Sean Nguyen; Pamela J Tsing
Journal:  Fed Pract       Date:  2021-05

8.  Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion.

Authors:  T A Stein; B Bailey; G P Burns
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Capecitabine-induced cardiotoxicity: case report and review of the literature.

Authors:  C Ang; M Kornbluth; M P Thirlwell; R D Rajan
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

10.  5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Authors:  Yama Fakhri; Morten Dalsgaard; Dorte Nielsen; Per Lav Madsen
Journal:  BMJ Case Rep       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.